Skip to main
HNGE

HNGE Stock Forecast & Price Target

HNGE Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 60%
Hold 7%
Sell 0%
Strong Sell 0%

Bulls say

Hinge Health is well-positioned for success with its innovative technology platform addressing the growing demand for MSK pain treatment. Along with introducing new products, the company is focused on expanding its market reach and gaining FDA clearance for its migraine treatment. This, along with their commitment to quality care and partnerships with providers, makes Hinge Health a strong investment opportunity with the potential for significant revenue growth.

Bears say

Hinge Health is a digital healthcare company leveraging AI technology to automate care for joint and muscle health, with little expected financial impact until 2027. The company's new product, HingeSelect, is poised to improve overall yield by capturing additional musculoskeletal spend, and management is optimistic that AI tools and operating discipline will drive efficiency gains. However, the company's operating margin target does not rely on pricing or ASP expansion, and the majority of migraine utilization data is not expected until next year, suggesting limited short-term growth potential for investors.

HNGE has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 60% recommend Buy, 7% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hinge Health Inc (HNGE) Forecast

Analysts have given HNGE a Buy based on their latest research and market trends.

According to 15 analysts, HNGE has a Buy consensus rating as of Aug 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $94.73, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $94.73, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hinge Health Inc (HNGE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.